Efficacy and safety studies of a recombinant chimeric respiratory syncytial virus FG glycoprotein vaccine in cotton rats

被引:28
作者
Prince, GA
Capiau, C
Deschamps, M
Fabry, L
Garçon, N
Gheysen, D
Prieels, JP
Thiry, G
Van Opstal, O
Porter, DD
机构
[1] Vir Syst Inc, Rockville, MD 20850 USA
[2] SmithKline Beecham Biol, B-1330 Rixensart, Belgium
[3] Univ Calif Los Angeles, Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA
关键词
D O I
10.1128/JVI.74.22.10287-10292.2000
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Several formulations of a recombinant chimeric respiratory syncytial virus (RSV) vaccine consisting of the extramembrane domains of the F and G glycoproteins (FG) were tested in cotton rats to evaluate efficacy and safety. The FG vaccine was highly immunogenic, providing nearly complete resistance to pulmonary infection at doses as low as 25 ng in spite of inducing relatively low levels of serum neutralizing antibody at low vaccine doses. Upon RSV challenge animals primed,vith FG vaccine showed quite mild alveolitis and interstitial pneumonitis, which were eliminated by the addition of monophosphoryl lipid A to the formulation.
引用
收藏
页码:10287 / 10292
页数:6
相关论文
共 36 条
[1]   Complete protection of mice from respiratory syncytial virus infection following mucosal delivery of synthetic peptide vaccines [J].
Bastien, N ;
Trudel, M ;
Simard, C .
VACCINE, 1999, 17 (7-8) :832-836
[2]   MOLECULAR-CLONING AND SEQUENCING OF THE F AND 22K MEMBRANE-PROTEIN GENES OF THE RSS-2 STRAIN OF RESPIRATORY SYNCYTIAL VIRUS [J].
BAYBUTT, HN ;
PRINGLE, CR .
JOURNAL OF GENERAL VIROLOGY, 1987, 68 :2789-2796
[3]   PARENTERAL ADMINISTRATION OF LIVE RESPIRATORY SYNCYTIAL VIRUS-VACCINE - RESULTS OF A FIELD TRIAL [J].
BELSHE, RB ;
VANVORIS, LP ;
MUFSON, MA .
JOURNAL OF INFECTIOUS DISEASES, 1982, 145 (03) :311-319
[4]   PROTECTION OF COTTON RATS AGAINST HUMAN RESPIRATORY SYNCYTIAL VIRUS BY VACCINATION WITH A NOVEL CHIMERIC FG GLYCOPROTEIN [J].
BRIDEAU, RJ ;
WALTERS, RR ;
STIER, MA ;
WATHEN, MW .
JOURNAL OF GENERAL VIROLOGY, 1989, 70 :2637-2644
[5]   Partial protection to respiratory syncytial virus (RSV) elicited in mice by intranasal immunization using live staphylococci with surface-displayed RSV-peptides [J].
Cano, F ;
Plotnicky-Gilquin, H ;
Nguyen, TN ;
Liljeqvist, S ;
Samuelson, P ;
Bonnefoy, JY ;
Ståhl, S ;
Robert, A .
VACCINE, 2000, 18 (24) :2743-2752
[6]   FIELD EVALUATION OF A RESPIRATORY SYNCYTIAL VIRUS VACCINE AND A TRIVALENT PARAINFLUENZA VIRUS VACCINE IN A PEDIATRIC POPULATION [J].
CHIN, J ;
MAGOFFIN, RL ;
SHEARER, LA ;
SCHIEBLE, JH ;
LENNETTE, EH .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1969, 89 (04) :449-+
[7]   PULMONARY HISTOPATHOLOGY INDUCED BY RESPIRATORY SYNCYTIAL VIRUS (RSV) CHALLENGE OF FORMALIN-INACTIVATED RSV-IMMUNIZED BALB/C MICE IS ABROGATED BY DEPLETION OF CD4+ T-CELLS [J].
CONNORS, M ;
KULKARNI, AB ;
FIRESTONE, CY ;
HOLMES, KL ;
MORSE, HC ;
SOTNIKOV, AV ;
MURPHY, BR .
JOURNAL OF VIROLOGY, 1992, 66 (12) :7444-7451
[8]   COTTON RATS PREVIOUSLY IMMUNIZED WITH A CHIMERIC RSV FG GLYCOPROTEIN DEVELOP ENHANCED PULMONARY PATHOLOGY WHEN INFECTED WITH RSV, A PHENOMENON NOT ENCOUNTERED FOLLOWING IMMUNIZATION WITH VACCINIA RSV RECOMBINANTS OR RSV [J].
CONNORS, M ;
COLLINS, PL ;
FIRESTONE, CY ;
SOTNIKOV, AV ;
WAITZE, A ;
DAVIS, AR ;
HUNG, PP ;
CHANOCK, RM ;
MURPHY, BR .
VACCINE, 1992, 10 (07) :475-484
[9]   ENHANCED PULMONARY HISTOPATHOLOGY INDUCED BY RESPIRATORY SYNCYTIAL VIRUS (RSV) CHALLENGE OF FORMALIN-INACTIVATED RSV-IMMUNIZED BALB/C MICE IS ABROGATED BY DEPLETION OF INTERLEUKIN-4 (IL-4) AND IL-10 [J].
CONNORS, M ;
GIESE, NA ;
KULKARNI, AB ;
FIRESTONE, CY ;
MORSE, HC ;
MURPHY, BR .
JOURNAL OF VIROLOGY, 1994, 68 (08) :5321-5325
[10]   CURRENT APPROACHES TO THE DEVELOPMENT OF VACCINES AGAINST DISEASE CAUSED BY RESPIRATORY SYNCYTIAL VIRUS (RSV) AND PARAINFLUENZA VIRUS (PIV) - A MEETING REPORT OF THE WHO PROGRAM FOR VACCINE DEVELOPMENT [J].
CROWE, JE .
VACCINE, 1995, 13 (04) :415-421